BioCentury
ARTICLE | Company News

Anchor Therapeutics, J&J deal

January 17, 2011 8:00 AM UTC

Anchor received an undisclosed cash payment from Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary under a 2010 deal to use Anchor's pepducins technology to discover and develop...